Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Revvity is a global life sciences and diagnostics company formed in 2023 following the rebranding of PerkinElmer. The company operates in two segments: life sciences, which provides reagents and instruments for biopharma and academic research, and...
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Revvity (NYSE:RVTY) through any online brokerage.
Other companies in Revvity’s space includes: Thermo Fisher Scientific Inc (NYSE:TMO), Danaher Corp (NYSE:DHR), Agilent Technologies Inc (NYSE:A), Waters Corp (NYSE:WAT) and IQVIA Holdings Inc (NYSE:IQV).
Revvity has a consensus price target of $117.05.
The stock price for Revvity (NYSE: RVTY) is $152.11 last updated October 6, 2026 at 6:44 PM EDT.
There are no upcoming dividends for Revvity.
Revvity does not have any upcoming earnings scheduled.
There is no upcoming split for Revvity.
Revvity is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NYSE.